Literature DB >> 28839623

Systemic mastocytosis: a gastroenterological perspective.

Hamish Philpott1, Paul Gow2, Peter Crowley3, Sanjay Nandurkar1, Jo Douglass4, Peter R Gibson1.   

Abstract

A 53 year old woman presented with abnormal liver function tests and subsequently developed intermittent abdominal pain, vomiting and diarrhoea. There were no rash or anaphylactoid reactions. Endoscopic biopsies showed excessive density of eosinophils and immunohistochemical staining for tryptase revealed a florid mast cell infiltrate. A diagnosis of systemic mastocytosis was made by bone marrow biopsy. Systemic mastocytosis is a rare myeloid neoplasm often associated with gastrointestinal symptoms due usually to mediator release but may rarely represent organ infiltration. While endoscopic and routine biopsy appearances are non-specific, suggestive features should lead to staining for mast cell tryptase or CD 117. However, diagnose generally requires bone marrow biopsy. The prognosis in the majority of patients is good and supportive management only is required. For patients with aggressive disease, cytoreductive therapy may be needed.

Entities:  

Year:  2011        PMID: 28839623      PMCID: PMC5517246          DOI: 10.1136/flgastro-2011-100013

Source DB:  PubMed          Journal:  Frontline Gastroenterol        ISSN: 2041-4137


  14 in total

1.  Normal and neoplastic mast cells.

Authors:  B S Wilkins; B J Bain
Journal:  Br J Haematol       Date:  1999-07       Impact factor: 6.998

Review 2.  Smouldering mastocytosis: a novel subtype of systemic mastocytosis with slow progression.

Authors:  Peter Valent; Cem Akin; Wolfgang R Sperr; Hans-Peter Horny; Dean D Metcalfe
Journal:  Int Arch Allergy Immunol       Date:  2002-02       Impact factor: 2.749

3.  How I treat patients with advanced systemic mastocytosis.

Authors:  Peter Valent; Wolfgang R Sperr; Cem Akin
Journal:  Blood       Date:  2010-09-20       Impact factor: 22.113

4.  Mast cell activation syndrome: Proposed diagnostic criteria.

Authors:  Cem Akin; Peter Valent; Dean D Metcalfe
Journal:  J Allergy Clin Immunol       Date:  2010-10-28       Impact factor: 10.793

Review 5.  Systemic mastocytosis.

Authors:  Peter Valent
Journal:  Cancer Treat Res       Date:  2008

6.  Omalizumab is effective in treating systemic mastocytosis in a nonatopic patient.

Authors:  J A Douglass; K Carroll; A Voskamp; P Bourke; A Wei; R E O'Hehir
Journal:  Allergy       Date:  2009-11-04       Impact factor: 13.146

Review 7.  Systemic mastocytosis and other mast cell neoplasms.

Authors:  B J Bain
Journal:  Br J Haematol       Date:  1999-07       Impact factor: 6.998

Review 8.  Mast cells and mastocytosis.

Authors:  Johan D Söderholm
Journal:  Dig Dis       Date:  2010-03-04       Impact factor: 2.404

Review 9.  Gastrointestinal manifestations of systemic mastocytosis.

Authors:  Jason K Lee; Scott J Whittaker; Robert A Enns; Peter Zetler
Journal:  World J Gastroenterol       Date:  2008-12-07       Impact factor: 5.742

10.  Systemic mastocytosis involving the gastrointestinal tract: clinicopathologic and molecular study of five cases.

Authors:  Richard Kirsch; Karel Geboes; Neil A Shepherd; Gert de Hertogh; Nando Di Nicola; Sylvie Lebel; Ugnius Mickys; Robert H Riddell
Journal:  Mod Pathol       Date:  2008-10-17       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.